#AACR17: Novel Drug Advancing to Phase II Basket Trial of Solid Tumors - Memorial Sloan Kettering Cancer Center (blog)

Memorial Sloan Kettering Cancer Center (blog)

#AACR17: Novel Drug Advancing to Phase II Basket Trial of Solid Tumors Memorial Sloan Kettering Cancer Center (blog) ... one month of treatment) and durable (lasting more than two years) responses across five cancers: non-small cell lung cancer, metastatic colorectal cancer, mammary analogue secretory carcinoma (a rare cancer of the salivary gland), renal cell ...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nG7ng5
via IFTTT